Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

BUY
$337.92 - $470.1 $106 Million - $147 Million
312,600 Added 52.13%
912,200 $316 Million
Q4 2023

Feb 14, 2024

BUY
$451.42 - $524.21 $100 Million - $116 Million
221,600 Added 58.62%
599,600 $275 Million
Q3 2023

Nov 14, 2023

BUY
$424.29 - $501.07 $4.67 Million - $5.51 Million
11,000 Added 3.0%
378,000 $184 Million
Q2 2023

Aug 14, 2023

BUY
$443.86 - $535.96 $13.2 Million - $16 Million
29,800 Added 8.84%
367,000 $164 Million
Q1 2023

May 15, 2023

SELL
$476.57 - $513.28 $54.9 Million - $59.1 Million
-115,100 Reduced 25.45%
337,200 $164 Million
Q4 2022

Feb 14, 2023

BUY
$497.04 - $563.0 $90.3 Million - $102 Million
181,700 Added 67.15%
452,300 $232 Million
Q3 2022

Nov 14, 2022

BUY
$458.85 - $502.89 $27 Million - $29.6 Million
58,900 Added 27.82%
270,600 $131 Million

Others Institutions Holding HUM

About HUMANA INC


  • Ticker HUM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 126,554,000
  • Market Cap $47.3B
  • Description
  • Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services t...
More about HUM
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.